Sienna Biopharmaceuticals, Inc. (SNNAQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 26, 2025, 8:00 PM EDT
Sienna Biopharmaceuticals Market Cap
Sienna Biopharmaceuticals has a market cap or net worth of $2.28 thousand as of October 29, 2025. Its market cap has decreased by -98.82% in one year.
Market Cap
2.28K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 27, 2017, Sienna Biopharmaceuticals's market cap has decreased from 368.04M to 2.28K, a decrease of -100.00%. That is a compound annual growth rate of -76.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 2.28K | 9,804.35% |
| Dec 30, 2024 | 23.00 | - |
| Dec 19, 2023 | 23.00 | - |
| Dec 28, 2022 | 23.00 | -99.99% |
| Dec 31, 2020 | 156.90K | -84.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |